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ThailandOver the past decades, the malaria burden in Thailand has substantially declined. Most infections now
originate from the national border regions. In these areas, the prevalence of asymptomatic infections is
still substantial and poses a challenge for the national malaria elimination program. To determine epi-
demiological parameters as well as risk factors for malaria infection in western Thailand, we carried
out a cohort study in Kanchanaburi and Ratchaburi provinces on the Thailand-Myanmar border. Blood
samples from 999 local participants were examined for malaria infection every 4 weeks between May
2013 and Jun 2014. Prevalence of Plasmodium falciparum and Plasmodium vivax was determined by quan-
titative PCR (qPCR) and showed a seasonal variation with values fluctuating from 1.7% to 4.2% for P. vivax
and 0% to 1.3% for P. falciparum. Ninety percent of infections were asymptomatic. The annual molecular
force of blood-stage infection (molFOB) was estimated by microsatellite genotyping to be 0.24 new infec-
tions per person-year for P. vivax and 0.02 new infections per person-year for P. falciparum. The distribu-
tion of infections was heterogenous, that is, the vast majority of infections (>80%) were found in a small
number of individuals (<8% of the study population) who tested positive at multiple timepoints.
Significant risk factors were detected for P. vivax infections, including previous clinical malaria, occupa-
tion in agriculture and travel to Myanmar. In contrast, indoor residual spraying was associated with a
protection from infection. These findings provide a recent landscape of malaria epidemiology and empha-
size the importance of novel strategies to target asymptomatic and imported infections.
 2020 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is an
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
In recent years, significant progress has been made in control-
ling malaria worldwide. The malaria incidence and mortality rates
of Southeast Asia declined by approximately 50% between 2000
and 2015 (WHO, 2015). In the same period, the number of malaria
cases in Thailand was reduced from 150,000 to 24,850 (ThaiDDC,
2016). The incidence rate in most areas is now below 1 case per1000 person-years at risk. As part of the global malaria elimination
effort, the country is aiming to achieve malaria elimination before
2025 (WPRO, 2015), a commendable goal which will require com-
mitment from all parties involved.
Notwithstanding the recent success in reducing the malaria
burden, a significant proportion of the population living in ende-
mic areas of Thailand is still at risk of Plasmodium spp. infections.
Historically, Plasmodium falciparum was the predominant parasite
species in Thailand, but Plasmodium vivax has recently taken over
as the primary parasite whereas Plasmodium malariae, Plasmodium
ovale and Plasmodium knowlesi are only found sporadically
(ThaiMoPH, 2017). Malaria infections in Thailand are seasonal,
the peak season lasting from May to September (Phimpraphi
et al., 2008). Transmission is concentrated along the western
Myanmar border and the eastern Cambodian border. Cross border
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of the disease (Sriwichai et al., 2017). Anopheles dirus, Anopheles
minimus and Anopheles maculatus are the most important local
malaria vectors in these parts of the country (Tananchai et al.,
2012; Sriwichai et al., 2016). Recently, an increasing number of
clinical infections were also reported from the southern provinces
(ThaiMoPH, 2017) which is likely due to reduced surveillance and
control activities as a result of political unrest in the area.
Several studies have reported the presence of a large number of
asymptomatic infections in Thailand (Li et al., 2014; Baum et al.,
2015, 2016; Parker et al., 2015; Nguitragool et al., 2017). As most
asymptomatic carriers do not seek treatment, they are a neglected
reservoir that may help sustain disease transmission (Kiattibutr
et al., 2017). To accelerate progress towards elimination, it is impor-
tant for the national malaria program to have an appropriate strat-
egy to manage these infections. A better understanding of which
individuals are at the greatest risk of harboring infections, symp-
tomatic or asymptomatic, is thus of fundamental importance, espe-
ciallywhen resources formalaria control are limited. At present, the
Thai nationalmalaria control program reliesmostly on clinical cases
detected at health facilities as the main indicator of malaria inci-
dence to coordinate its control efforts. Data on asymptomatic infec-
tion rates in Thailand are thus restricted to cross-sectional surveys
conducted in a few areas (Kritsiriwuthinan and Ngrenngarmlert,
2011; Li et al., 2014; Baum et al., 2015, 2016; Parker et al., 2015).
In this study, we sought to better understand the dynamics of
malaria infection and its risk factors in populations along the
Thailand-Myanmar border, an area where malaria infection rates
are still substantially higher than in other parts of Thailand. We
conducted a longitudinal cohort study in two villages between
May 2013 and Jun 2014 in which finger-prick blood samples were
obtained from participants every 4 weeks. Malaria parasites were
detected by qPCR and parasite genotypes were assessed by ampli-
fication of length polymorphic markers. Parasite positivity and
molecular force of blood-stage infection (molFOB, the rate of acqui-
sition of new blood-stage clones) (Mueller et al., 2012; Koepfli
et al., 2013) were used to quantify the risk of infection as well as
the underlying risk factors.2. Materials and methods
2.1. Study sites
This studywas conducted in two villages, one in the Bong Ti sub-
district of Kanchanaburi province and the other in the Suan Phueng
subdistrict of Ratchaburi Province of Thailand (Fig. 1). These two
sites are located within a few km of the Thailand-Myanmar border.
The main ethnic groups in both sites were Thai and Karen. Agricul-
ture and farming were the main occupations. Forest foraging was a
frequent activity for residents in these areas. The village of Bong Ti
is located approximately 65 km west of the main district of Kan-
chanaburi province in a hilly terrain. Most houses were accessible
by paved roads. A cross-sectional survey of malaria infection by
qPCR (Nguitragool et al., 2017) indicated 3.8% Plasmodium vivax
and 1.4% P. falciparum prevalence in August-September of 2012.
The study village in Suan Phueng subdistrict is located approxi-
mately 160 km from Bangkok. The village is located in a mountain-
ous area on the Tanaosri mountain range. Our survey in September-
October of 2012 indicated a prevalence of 3.1% for P. vivax and 1.2%
for P. falciparum at this site (Nguitragool et al., 2017).2.2. Study design
A total of 999 participants were enrolled for a 1 year prospec-
tive cohort study. No treatment was given at the baseline. A totalof 14 visits to each study participant were made between May
2013 and June 2014, with time between consecutive visits being
approximately 4 weeks. A finger prick blood sample was collected
from each participant at each visit for malaria parasite detection,
species identification, and genotyping by length polymorphic
markers for molFOB determination. Additional finger prick blood
samples were also obtained through passive case detection, when
participants visited malaria clinics in the study areas during the
time between study visits.
At each visit, participants were asked to provide information
regarding factors relevant for malaria control including access to
and usage of insecticide-treated nets, travel history, clinical
malaria history, and treatment taken since the last visit. Before tak-
ing the blood sample, the body temperature of each participant
was measured using an infrared thermometer. Participants with
fever (body temperature 37.5 C) were tested for malaria infec-
tion on-site using a rapid diagnostic test (SD BIOLINE Malaria Ag
P.f./Pan, Standard Diagnostics, Republic of Korea) and referred to
a nearby malaria clinic for treatment if the test was positive. The
study was approved by the Ethics Committee of the Faculty of
Tropical Medicine, Mahidol University, Thailand (EC approval
number TMEC 13-020).
2.3. Molecular analysis
Finger prick whole blood (200 ll) was collected from each par-
ticipant into an EDTA-containing microtainer. After plasma
removal, blood pellets were stored at 20 C until DNA extraction.
DNA was extracted using FavorPrep 96-well Genomic DNA Extrac-
tion Kits (Favorgen, Taiwan), following the standard protocol pro-
vided by the manufacturer. The final purified DNA was eluted
into 100 ll of elution buffer. A volume of 4 ll of purified DNA
(equivalent to 8 ll of whole blood) was used as the template for
malaria parasite detection by a genus-specific qPCR assay targeting
the Plasmodium 18S rRNA genes (Wampfler et al., 2013). For sam-
ples positive by the genus-specific assay, P. vivax- and P. falci-
parum-specific assays (Rosanas-Urgell et al., 2010) were used to
determine the parasite species. Plasmodium vivax genotypes were
determined using PvMS2 and Pvmsp1F3 markers as previously
described (Schoepflin et al., 2009). The combined expected
heterozygosity, He, of the two markers was 0.89. Capillary elec-
trophoresis for microsatellite genotyping was performed on an
ABI3730XL instrument (Macrogen, Republic of Korea).
2.4. Determination of the molecular force of blood infection (molFOB)
The molecular force of blood infection (molFOB) was determined
as described previously (Koepfli et al., 2013). Briefly, the molFOB is
the observed number of new blood-stage infections, as identified
by individual parasite genotypes, divided by the time-at-risk (i.e.,
the incidence of new blood-stage infections). An observed infec-
tion, as identified by a specific genotype, was considered to be
‘new’ if the same genotype had not been seen in the two previous
active or passive case detection visits. As such, the molFOB can be
determined for each study participant or as a sum over the entire
study population or subpopulations.
2.5. Statistical analysis
Factors influencing i) the overall rate of acquisition of new
blood infections (molFOB); ii) being parasite-positive for P. vivax
and/or P. falciparum and iii) being subject to a clinical episode,
defined by fever + parasitemia detectable by light microscopy
(Robinson et al., 2015) were investigated using statistical models.
Travel to Myanmar was quantified as ‘trips per year’ based on
answers to questions about travel history at each visit. Since the
Fig. 1. Map of the two study sites in Bong Ti, Kanchanaburi and Suan Phueng, Ratchaburi on the Thailand-Myanmar border. Study households are shown (d) as well as
households in which infections with Plasmodium falciparum or Plasmodium vivax were detected over the course of the study (w).
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exposure time (time at risk), and is overdispersed, a negative bino-
mial regression model was chosen in which the exposure time at
risk is used as tge offset (m*j = exp(bxj + offsetj + mj), where off-
setj = log(exposure time) and emj follows a gamma distribution.
Because using the collapsed data to model the molFOB for each indi-
vidual does not allow for the analysis of time-changing covariates,
factors influencing the frequency of parasite positivity and fre-
quency of clinical episodes within the study period were explored
using multiple failure time models allowing for time-changing
covariates (Therneau and Grambsch, 2000). In these models, para-
site positivity and clinical episodes were equivalent to a ‘failed’
outcome, respectively. In addition to the statistical models pre-
sented in the main manuscript, univariate analyses (Supplemen-
tary Tables S1, S3, S5, S7) and multivariate analyses with
backward selection (Supplementary Tables S2, S4, S6) are provided.
To test whether infections were spatially correlated, the molFOB
was tested for spatial autocorrelation using the Moran’s I test
statistic, which takes into account the value of the molFOB for each
location and the distance between all locations. A Morans I > 0
indicates spatial clustering of high/high and/or low/low molFOB val-
ues. This analysis was done once for each individual, accepting thatthe distance between individuals in the same household is 0, and
once for each household by calculating the average molFOB per
household (i.e., the total number of new infections divided by the
total time at risk per household).3. Results
3.1. Characteristics of the study population
In total, 999 participants were enrolled into this study in May
2013. Eight hundred and twelve participants were from Bong Ti,
Kanchanaburi and 187 participants were from Suan Phueng, Ratch-
aburi. Fig. 1 shows the maps of these two study sites where the
household locations of the study participants were marked.
Of the 999 participants, the large majority (n = 799, 80%) were
seen 13 or more times (interquartile range (IQR): 13–14; range:
1–14) during the study period resulting in 12,559 blood samples
from active case detection (ACD). In addition, 281 blood samples
were obtained through passive case detection (PCD) when partici-
pants presented at local malaria clinics due to illness. The median
time that the participants remained in the study was 368 days
458 W. Nguitragool et al. / International Journal for Parasitology 49 (2019) 455–462(IQR: 361–379; range: 0–378). An overview of the characteristics
of the study population is given in Table 1.Fig. 2. Prevalence and molecular force of blood-stage infection ( FOB) of3.2. Parasite prevalence and molFOB
From samples collected at both ACD and PCD visits, the genus-
specific PCR assay detected 735 infections in the study partici-
pants, of which 512 (70.0%) were successfully genotyped for the
molFOB (i.e. the incidence of genetically distinct blood-staged infec-
tions) analysis. Plasmodium vivax monoinfections constituted
84.6% (n = 433/512), P. falciparum monoinfections 9.2%
(n = 47/512) and mixed species infections 6.3% (n = 32/512). As
such, mixed species infections were over-represented by a factor
of approximately 10 (Fisher’s exact test, P < 0.001) indicating a
strong clustering of infection. A proportion of 8.5% (37/433) of P.
vivax infections and 21.3% (10/47) of the P. falciparum infections
were classified as clinical, i.e., detectable parasitemia was accom-
panied by a measured or reported fever in either PCD or ACD visits.
The difference is statistically significant (analysis of proportions,
chi-square test, P = 0.006) and suggests that P. falciparumwas more
likely to cause clinical symptoms. Notably, none of the 32 mixed
infections was classified as a clinical episode.
The prevalence of P. falciparum and P. vivax showed seasonal
variation with prevalence varying from 4.2% to 1.7% for P. vivax
and from 1.3% to 0% for P. falciparum (Fig. 2). The peak between
June and September coincided with the rainy season.
During the study period, an estimated total of 226 new (i.e.
genetically distinct) P. vivax and 18 new P. falciparum blood-stage
infections were detected, resulting in an average molFOB of 0.24
new infections per person-year for P. vivax and 0.02 new infections
per person-year for P. falciparum. The seasonal variation of the mol-
FOB resembled that of parasite prevalence for both species, with
the peak in the wet season.mol
Plasmodium vivax (A) and Plasmodium falciparum (B) at each study site by month
of study visit. Error bars (prevalence) represent the upper limit of the 95%
confidence interval; shaded area (molFOB) represents S.E.M. Note that molFOB could
not be determined for visits one and two as it depends on the observations from
two previous study visits.3.3. Clustering of new infections
A number of study participants experienced a disproportion-
ately high molFOB (Fig. 3). The excess of high molFOB values com-
pared with the homogeneous distribution (Poisson) is
statistically significant for P. vivax (goodness of fit test for Poisson
distribution P < 106), suggesting either a non-uniform risk of
acquiring new infection through mosquito bites or relapses of par-
asites from the liver. Spatial analysis suggests that the P. vivax mol-
FOB in Bong Ti, Kanchanaburi was clustered at both the individual
level (global Moran’s I = 0.12, P < 0.0001) and, more loosely, at theTable 1
Characteristics of the western Thailand study population.
Characteristic n (%) or median (range)
Agea (yr) 23 (1–83)
Male/Female 452 (46.2)/527 (53.8)
Kanchanaburi/Ratchaburi 812 (81.3)/187 (18.7)
Exposure (days) 368 (22–378)
Infection status at first visit
Plasmodium vivax 34 (3.4)
Plasmodium falciparum 7 (0.8)
Mixed P. vivax/P. falciparum 3 (0.3)
Insecticide treated net possession/usagea
Never 62 (6.3)
<6 months 11 (1.1)
6 months–1 year 12 (1.2)
1 year–2 years 34 (3.5)
>2 years 860 (87.8)
Indoor residual sprayinga 719 (73%)
Window screensa 20 (0.2%)
a At first visit (May 2013).household level (global Moran’s I = 0.03, P = 0.02). The low number
of infections precluded an in-depth analysis of heterogeneities in
the risk of P. falciparum infection.
3.4. Factors associated with P. vivax infection and illness
The age profile of the molFOB for P. vivax revealed a higher num-
ber of new blood-stage clones in adolescents and adults compared
with children (Fig. 4). In addition to age, analysis of risk factors
revealed that increased frequency of travel to Myanmar, previous
malaria episodes, and employment in agriculture were signifi-
cantly associated with increased risk of new P. vivax blood-stage
infections as measured by the molFOB (Table 2).
In order to assess time changing covariates, risk factors associ-
ated with P. vivax positivity were also determined using a multiple
failure time model (Table 3). In general, predictors of P. vivax mol-
FOB were predictors of P. vivax positivity. While similar effect sizes
were observed, the analysis of P. vivax positivity additionally
detected indoor residual spraying (IRS) as a significant factor asso-
ciated with reduced risk of infection.
Several predictors of P. vivax infection including season, age,
occupation, and reported previous clinical malaria, were also sig-
nificantly associated with clinical episodes of malaria (Table 4).
Notably, while adult age was a predictor of increased risk of infec-
tion (Tables 2 and 3), it was associated with a reduced risk of clin-
ical episodes (Table 4). This indicates stronger protective immunity
Fig. 3. Distributions of the molecular force of blood-stage infection (molFOB). The
proportion of study participants at each level of molFOB is shown for Plasmodium
vivax (A) and Plasmodium falciparum (B). Red: normalized distributions of observed
molFOB in the study participants. Grey: Poisson distributions computed based on the
mean molFOB. The Poisson distributions are overlaid on top of the observed
distributions.
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mar was a predictor of infection and IRS was associated with a
reduced risk of infection, these two factors were not significantly
associated with clinical episodes. This is consistent with their
expected relationship with parasite exposure but not clinical out-
comes. Interestingly, despite the lack of association of bednet
usage with P. vivax molFOB and positivity, bednet usage was signif-
icantly associated with a small reduction in clinical episodes. The
reason for this is unclear and may deserve further investigation.
None of the mixed species infections (P. falciparum/P. vivax,
n = 32) corresponded to a clinical episode, possibly reflecting
parasite-parasite interaction or co-development of host protective
immunity against these sympatric species.
3.5. Factors associated with P. falciparum infection
For P. falciparum, risk factors for increased molFOB were not
determined due to the small number of observations (n = 18 new
P. falciparum infections out of 12,559 samples). Predictors of infec-
tion were determined only from positivity data. In the univariate
analysis, only travel frequency to Myanmar was found to be a pre-
dictor of parasite positivity (Supplementary Table S7). The small
number of detected P. falciparum infections did not allow detection
of other risk factors. Based on the results presented in Table 5, how-
ever, season, age, male gender and IRS may also show association
with a higher infection rate in a larger, more highly powered, study.4. Discussion
This study has confirmed the high degree of heterogeneity of
malaria risk in Thai populations living along the Thailand – Myan-
mar boarder and identified important risk factors for P. vivax infec-
tion and disease. One key epidemiological parameter determined
in this study is the molFOB which reflects the rate of acquiring a
new blood-stage clone of the parasite. Two genetic markers
(PvMS2 and Pvmsp1F3) were used to genotype P. vivax. Because
the combined He of the two loci was 0.89, approximately 10% of
all new clones are expected to have been missed. This, together
with the limited sensitivity of molecular genotyping (69.5% of sam-
ples were PvMS2-positive; 78.9% of samples were Pvmsp1F3-
positive), would lead to an underestimation of the true molFOB.
These limitations are shared by our previous studies using the
same methodology (Mueller et al., 2012; Koepfli et al., 2013;
Hofmann et al., 2017). The analyses of risk factors, however,
depends only on the relative values of the molFOB.
Overall the prevalences of P. falciparum (0–1.3%) and P. vivax
(1.7–4.2%) were similar to the 4.9–5.7% Plasmodium prevalence
previously reported in Kanchanaburi and Ratchaburi in 2012
(Patel et al., 2014; Nguitragool et al., 2017). The majority of infec-
tions detected at each visit were asymptomatic and resolved natu-
rally without developing into clinical malaria. Using the same
dataset, we recently estimated the duration of blood-stage infec-
tion detectable by molecular genotyping to be 29 days for P. vivax
and 135 days for P. falciparum (White et al., 2018).
The overall prevalence as well as the predominance of P. vivax
infections reflect the current trend in Thailand and the Greater
Mekong Subregion where P. vivax has become the predominant
malaria species (Baum et al., 2015; Imwong et al., 2015;
Nguitragool et al., 2017). The P. vivax pre-dominance is less pro-
nounced among the clinical/febrile cases (Pv: 79%) than asymp-
tomatic infections (Pv: 91.5%). The predominance was most
striking in the number of genetically distinct blood-stage infec-
tions acquired during follow-up (molFOB) with only 7.4% of all
newly acquired infections due to P. falciparum, resulting in an aver-
age molFOB of 0.02 and 0.24 new infections per person-year for P.
falciparum and P. vivax, respectively. The proportion of P. vivax
infection relative to P. falciparum was much higher in our cohort
than among clinical cases recorded by the Thai health system
(ThaiDDC, 2016; WHO, 2016), indicating that the true burden of
(mostly asymptomatic) P. vivax infections in Thailand may be sub-
stantially higher than reported.
The risk of P. vivax infection was highly heterogeneous in our
study sites, which are fairly typical of areas along the Thailand-
Myanmar border where the landscape is mountainous, agriculture
and forest harvesting are the means of living, and cross-border
migrant workers are common. Only 15% of the 999 study partici-
pants tested positive during the study, and people who were
infected at multiple visits accounted for >80% of all infections.
The observed concentration of infections in a small sub-
population suggests that appropriate interventions targeted at
high-risk individuals may be effective in accelerating malaria
elimination.
In order to target malaria interventions more efficiently, it is
essential to better understand the geographical, demographic,
and behavioral risk factors for Plasmodium spp. infections in these
Thai border communities. For P. vivax, the risk factors for higher
parasite prevalence and molFOB were very similar and included
rainy season, aged 7–60 years, male gender, past experience of
clinical malaria, being employed in agriculture, and travel to Myan-
mar. As areas with perennial transmission, our study sites received
deltamethrin IRS twice each year according to the policy of the
Fig. 4. The molecular force of blood-stage infection (molFOB) as a function of age in the study population. (Aa) The average Plasmodium vivax molFOB in each age group. (Ab)
The proportion of individuals with P. vivax molFOB > 0 in each age group. (Ba) The average Plasmodium falciparum molFOB in each age group. (Bb) The proportion of individuals
with P. falciparum molFOB > 0 in each age group. Error bars indicate the S.E.M. (Aa, Ba) or the upper limit of the 95% confidence interval (Ab, Bb).
Table 2
Factors associated with Plasmodium vivax molFOB (negative binomial model) in
western Thailand.
Risk factor aIRR 95% CI P
Kanchanaburi 1.83 0.64–5.23 0.257
Age group (years; ref: 0–6)
7–12 22.79 3.34–155.6 <0.001
13–17 17.10 2.15–135.84
18–60 15.67 2.15–114.15
>60 3.85 0.44–33.31
Male 1.86 1.1–3.14 0.02
Frequency of travel to Myanmar
(per visit/year)
1.15 1.05–1.24 0.001
Previous clinical malariaa 2.43 1.2–4.91 0.014
House treated with IRSa 0.56 0.3–1.04 0.067
Reported bednet possessiona 0.98 0.39–2.43 0.957
Work in agriculturea 2.25 1.04–4.86 0.039
aIRR, adjusted incidence risk ratio; CI, confidence interval; IRS, indoor residual
spray
a Status at enrolment.
Table 3
Risk factors associated with western Thailand Plasmodium vivax positivity (multiple
failure time model).
Risk factor aHR P
Kanchanaburi 2.22 (1.06–4.76) 0.03
Season (May-September) 3.41 (2.19–5.31) <0.001
Age group (years; ref: 0–6)
7–12 3.64 (0.94–14.02) 0.02
13–17 4.99 (1.22–20.34)
18–60 3.69 (1.03–13.21)
>60 0.99 (0.22–4.48)
Male 2.32 (1.36–3.96) <0.001
Work in agriculturea 2.01 (1.14–3.55) 0.02
Frequency of travel to Myanmarb 1.06 (1.01–1.11) 0.01
Average bednet usageb,c 1 (0.95–1.05) 0.92
House treated with IRSa 0.47 (0.28–0.79) <0.001
Previous clinical malariaa 1.87 (1.13–3.1) 0.02
aHR, adjusted hazard ratio; IRS, indoor residual spray.
a Status at enrolment.
b As a time-changing covariate (average observed at time of outcome).
c Average bednet usage was defined as the proportion of times a person had
answered ‘yes’ to the question: ‘Did you sleep under a bednet last night?’ during
active case detection.
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vention was associated with reduced infection risk. Thus, even
though malaria infection risk was generally related to occupational
exposure (as exemplified by male adults working in agriculture or
in the forest and people visiting areas of higher transmission in
Myanmar), the high risk in children 7–17 years of age and the asso-
ciation of IRS with protection indicate ongoing local P. vivax trans-
mission, including in or near people’s houses. While the high risk inmale adults and those regularly crossing the Myanmar border has
been well established (Nguitragool et al., 2017), the association
between IRS and reduced P. vivax positivity was a surprise in light
of the predominantly outdoor biting preference of the malaria vec-
tors in western Thailand (Muenworn et al., 2009; Tananchai et al.,
Table 4
Risk factors associated with western Thailand Plasmodium vivax clinical episodes
(multiple failure time model).
Risk factor aHR P
Kanchanaburi 1.01 (0.3–3.33) 0.99
Season (May-September) 19.47 (1.82–208.79) 0.01
Age group (ref: 0–12)b
13–17 0.75 (0.19–3.05) <0.001
18–60 0.24 (0.1–0.6)
>60 0.35 (0.09–1.29)
Male 1.66 (0.63–4.36) 0.31
Work in agriculturec 4.64 (2.18–9.86) <0.001
Travel frequency to Myanmara 1.04 (0.94–1.15) 0.50
Average bednet usagea,d 0.89 (0.83–0.96) <0.001
IRSc 1.64 (0.61–4.45) 0.33
Previous clinical malariac 2.21 (0.98–4.97) 0.06
aHR, adjusted hazard ratio; IRS, indoor residual spray.
a As a time-changing covariate (floating average at time of outcome).
b The age groups were further aggregated when compared with Table 3, as some
age groups did not contain any positive outcomes.
c Status at enrolment.
d Average bednet usage was defined as the proportion of times a person had
answered ‘yes’ to the question: ‘Did you sleep under a bednet last night?’.
Table 5
Risk factors associated with western Thailand Plasmodium falciparum positivity
(multiple failure time model).
Risk factor aHR P
Kanchanaburi 1.69 (0.54–5.26) 0.36
Season (May–September) 2.12 (1.03–4.36) 0.04
Age group (years; ref: 0–6)
7–12 4.15 (0.38–45.23) 0.12
13–17 4.54 (0.45–46.25)
18 10 (1.1–91.05)
Male 2.9 (0.73–11.52) 0.13
Work in agriculturea 0.36 (0.05–2.63) 0.32
Travel frequency to Myanmarb 1.08 (0.96–1.22) 0.18
Average bednet usageb,c 1.04 (0.83–1.3) 0.76
IRSa 2.12 (0.77–5.82) 0.15
Previous clinical malariaa 0.96 (0.28–3.24) 0.95
aHR, adjusted hazard ratio; IRS, indoor residual spray.
a Status at enrolment.
b As a time-changing covariate (floating average at time of outcome).
c Average bednet usage was defined as the proportion of times a person had
answered ‘yes’ to the question: ‘Did you sleep under a bednet last night?’.
W. Nguitragool et al. / International Journal for Parasitology 49 (2019) 455–462 4612012; Tisgratog et al., 2012; Sriwichai et al., 2017). It provides a
strong argument for continued support for the national IRS pro-
gram in country.
The risk of suffering a clinical P. vivax episode was highest in
children <7 years of age and decreased strongly with age, indicat-
ing that residents with higher risks of P. vivax infections did
acquire substantial clinical immunity. Although it is well estab-
lished that immunity to P. vivax is acquired more rapidly than to
P. falciparum (Longley et al., 2016), it cannot be ruled out that at
least part of the immunity observed in older age groups was
acquired during earlier periods when transmission intensity was
substantially higher (Phimpraphi et al., 2008). Although they are
less infectious to mosquitoes than symptomatic infections
(Kiattibutr et al., 2017), asymptomatic P. vivax infections are much
more prevalent and may pose a particular challenge to malaria
elimination in Thailand. Overall, the observed risk patterns indi-
cate that residual transmission of P. vivax persists in our study
areas.
There was only a small number of P. falciparum-positive cases
detected during the study period. Due to this, for P. falciparum
the risk factor analysis was limited to qPCR positivity. Only fre-
quency of travel to Myanmar was found to be a statistically signif-icant determinant for risk of P. falciparum infection. Although not
statistically significant due to the profound lack of power, the mul-
tivariate analysis does indicate that the risk of P. falciparum was
highest in male (adjusted hazard ratio (aHR) = 2.9) adults
(aHR = 10.0) with an excess risk also during the rainy seasons
and in areas where IRS had been conducted. The higher risk in peo-
ple who traveled frequently across the border is a common feature
of the residual burden both in this (Nguitragool et al., 2017) and
other border regions of Thailand (Kitvatanachai et al., 2003;
Bhumiratana et al., 2013). As found in neighboring Tak province,
where P. falciparum malaria was four times more likely in recent
migrants compared with Thai patients and correlated with Anophe-
line vector capture rates (Sriwichai et al., 2017), this indicates that
importation of P. falciparum to Ratchaburi and Kanchanaburi con-
tributed significantly to prevalence.
To our knowledge, this study is the first from a hypoendemic
area to determine the molFOB. Previous studies of Plasmodium mol-
FOB were restricted to Papua New Guinea where transmission
intensity was much higher with molFOB in the range of 5–14 new
infections per person-year (Mueller et al., 2012; Koepfli et al.,
2013; Hofmann et al., 2017). These previous studies demonstrated
that in such a setting, acquisition of new P. falciparum clones was a
major factor of clinical malaria in children (Mueller et al., 2012)
and that high molFOB likely contributed to rapid acquisition of
immunity against P. vivaxmalaria (Koepfli et al., 2013). The molFOB
for both P. falciparum and P. vivaxwere at least 50-fold lower in the
current study. This study thus represents a scenario at the opposite
end of the malaria transmission spectrum.
Compared with parasite positivity, the molFOB is a more direct
measure of P. falciparum transmission. For P. vivax, the molFOB is
a combined measure of blood-stage infections arising from both
new mosquito bites and relapses. Without the knowledge about
the relative contributions of mosquito bites and relapses, it is dif-
ficult to estimate how much the molFOB reflects transmission
intensity. In this study, we found that the seasonal variation of par-
asite positivity closely followed that of the molFOB (Fig. 2) for both
parasite species. Risk factor analyses of the molFOB and positivity of
P. vivax also yielded similar results; all significant risk factors
apparent in the molFOB analysis were apparent in the analysis that
used positivity. The close association between P. vivax prevalence
and the molFOB is consistent with the short duration (29 days) esti-
mated for blood-stage infection in Thailand (White et al., 2018).
In summary, our study highlights the different challenges posed
by P. falciparum and P. vivax to Thailand’s declared goal of eliminat-
ing local malaria transmission by 2025. In line with our earlier
studies in Tak Province (Baum et al., 2015, 2016; Parker et al.,
2015; Sriwichai et al., 2017), we have confirmed the continued
presence of local P. vivax transmission in Thai villages along the
western border. Most of the P. vivax infections were asymptomatic
and often of very low density and would not have been detected by
the standard surveillance methods based on microscopy and cen-
tered around passive case detection. Efficient elimination of P.
vivax from Thailand will thus require additional novel strategies
targeting this asymptomatic reservoir, including the silent hypno-
zoite reservoir (Robinson et al., 2015). On the other hand, P. falci-
parum infections were rare. With a large proportion of infection
linked to recent travel to Myanmar, it will be important to
strengthen malaria control measures on both sides of the border
and to raise awareness of the travel-associated risk.
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